Blood-based biomarkers show why diverse groups are underrepresented in Alzheimer's trials, raising questions about risk factors beyond amyloid.

A new study is shedding light on why some of the people most at risk for Alzheimer’s disease are missing from clinical trials. Researchers from the...

A new study is shedding light on why some of the people most at risk for Alzheimer’s disease are missing from clinical trials. Researchers from the...

Alzheimer's is a neurodegenerative disease, and the most common form of dementia, accounting for 60-70 percent of cases,. In a November 25, 2024 video...

Alzheimer's is a neurodegenerative disease, and the most common form of dementia, accounting for 60-70 percent of cases,. In a November 25, 2024 video...

BAVINA SOOKDEO SEPTEMBER is Alzheimer’s Awareness Month and neurologist Dr Nicholas Maraj is urging the nation to face the growing challenge of...

Scientists at Emory University’s Goizueta Brain Health Institute and partner institutions have identified proteins in the blood that may shed new...

A major new study from RUSH University in Chicago has found more evidence that what we eat may have a big impact on our brain health, especially when...

In a landmark study of Hispanic and Latino adults, researchers at University of California San Diego School of Medicine have identified a link between...

In a landmark study of Hispanic and Latino adults, researchers at University of California San Diego School of Medicine have identified a link between...